Share ownership Bayer AG

BAYN

DE000BAY0017

Pharmaceuticals

Real-time Estimate Tradegate Other stock markets 12:08:53 10/12/2025 GMT			5-day change	1st Jan Change
36.17 ^EUR	-0.61%		+5.56%	+87.20%

11:44am	DCM Shriram and Bayer sign MoU for agriculture	RE
12-09	Frankfurt Stock Exchange closing: DAX continues to rise with the "handbrake on"	DP

Share class: Bayer AG

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	982,424,082	982,424,082 ( 100 %)	0	100 %

Major shareholders: Bayer AG

Name	Equities	%	Valuation
Silchester International Investors LLP 2.994 %	29,409,766	2.994 %	1 040 M €
Harris Associates LP 2.981 %	29,285,913	2.981 %	1 036 M €
Amundi Asset Management SASU (Investment Management) 2.971 %	29,188,372	2.971 %	1 033 M €
Dodge & Cox 2.874 %	28,233,293	2.874 %	999 M €
Cobas Asset Management SGIIC SA 0.2368 %	2,326,082	0.2368 %	82 M €
CapitalatWork SA 0.1723 %	1,692,317	0.1723 %	60 M €
Sjunde AP-fonden 0.1373 %	1,349,030	0.1373 %	48 M €
Research Affiliates LLC 0.0867 %	852,055	0.0867 %	30 M €
State Street Global Advisors Ltd. 0.0863 %	847,715	0.0863 %	30 M €
FIL Investments International (Germany) 0.0836 %	821,505	0.0836 %	29 M €
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Equities	%	Valuation
Kahn Brothers Group, Inc. 0.1727 %	6,787,253	0.1727 %	60 M €
Dodge & Cox 0.0398 %	1,562,425	0.0398 %	14 M €
Goldman Sachs Asset Management International 0.007721 %	303,393	0.007721 %	3 M €
Great Lakes Advisors LLC 0.003615 %	142,040	0.003615 %	1 M €
RhumbLine Advisers LP 0.001775 %	69,761	0.001775 %	617 036 €
Yousif Capital Management LLC 0.001655 %	65,040	0.001655 %	575 279 €
GAMMA Investing LLC 0.000951 %	37,371	0.000951 %	330 546 €
Moloney Securities Asset Management LLC 0.00077 %	30,240	0.00077 %	267 473 €
Wintrust Private Trust Co. NA 0.000692 %	27,191	0.000692 %	240 504 €
Ayalon Mutual Funds Ltd. 0.000445 %	17,500	0.000445 %	154 788 €
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Institutional	14.28%
Other	0.69%
Unknown	85.03%

Based on 1000 largest holdings

Geographical origin of shareholders

United States	6.91%
United Kingdom	3.27%
France	3.03%
Spain	0.39%
Germany	0.3%
Belgium	0.17%
Switzerland	0.16%
Sweden	0.14%
Italy	0.13%
Luxembourg	0.12%
Ireland	0.08%
South Africa	0.07%
Austria	0.05%
Denmark	0.04%
Finland	0.04%
Japan	0.02%
Australia	0.01%
Canada	0.01%
China	0.01%
Hong Kong	0.01%
Norway	0.01%
Liechtenstein	0.01%

Based on 1000 largest holdings

Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.8%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (38.9%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.6%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.2%), Switzerland (1.2%), Europe/Middle East/Africa (23.6%), the United States (31.7%), North America (3.6%), China (7.7%), Asia/Pacific (9.6%), Brazil (9.3%) and Latin America (8.1%).

Employees

88,502

Sector

Pharmaceuticals

Calendar

03-02 - Q4 2025 Earnings Release (Projected)

More about the company